Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

More documents

Recommendations

Info

APPENDIX 11. Independent Clinical Trials Service Companies (cont’d) 300 Types of Clients Regulatory Qualifications Hospital; Conforms to Clinic outpatients Good Clinical Practice/ International Conference on Harmonization ICH/GCP trained research staff Quality Assurance Compliance with ICH/GCP, local and central regulatory requirements Company/ URL Contact Information Therapeutic Expertise and Types of Services Structure Number and Type of Staffing Nanaimo Research Institute 515 B Campbell Street, Participates in Phase III and Phase IV national and inter- Independent orga- 8 staff: 2 physi- www.nri-nanaimo.ca Nanaimo, B.C. V9R 3G9 national clinical research in cardiology/ cardiovascular disnization located in cians (internal Tel: 250-714-1157; Fax: 250- eases, orthopedic, respiratory, diabetes and other metabolic Nanaimo B.C. medicine), 714-1163 disorders, and palliative care. Clinical research in both in 5 research nurses, nri@telus.net hospital and outpatient trials. Established in 1997 under the 1 research respi- directorship of Dr. Lawrence Winkler and Dr. Kevin Lai. ratory therapist OCT services comply with: Predominantly in North America and Canada; also Japan and Europe. Include Pharma Companies, SMEs, Hospitals, and Institutions requiring CT operations and services Employees 8 persons located in Kelowna 2 investigators 3 Study coordinators Studies conducted as out-patient visits from the Okanagan region of B.C. OCT conducts clinical trials on an out-patient basis for the pharmaceutical industry (primarily large pharma). Phase II - IV trials in a variety of therapeutic areas. Medical specialists, research co-ordinators and staff are equipped to undertake trials in psychiatry, gastroenterology, gynecology, urology, cardiology, neurology, pediatrics, ophthalmology. 204-1353 Ellis St Kelowna, B.C., V1Y 1Z9 Tel: 250-862-8141 Fax: 250-862- 8130 Paul Latimer dr@oktrials.ca Sally Godsell Okanagan Clinical Trials (OCT) www.oktrials.ca GCP BRITISH COLUMBIA
Types of Clients Regulatory Qualifications N/A Pharma, biotech, others Company/ URL Contact Information Therapeutic Expertise and Types of Services Structure Number and Type of Staffing Oxford Outcomes At least 2 people www.oxfordoutcomes.com located in Vancouver Consulting services led by a strong group of consultants and opinion leaders from health economics and outcomes research CLINICAL TRIALS AND PRECLINICAL INFRASTRUCTURE ASSET MAP International health outcomes consultancy with offices in the UK (Oxford), Canada (Vancouver and Toronto) and the US (Bethesda, MD and Morristown, NJ). Provides a broad spectrum of specialist services in: • patient reported outcomes research • health economics • epidemiology • infectious disease research • translation and linguistic validation. Supports the drug development lifecycle through early stage development and investment, market access, reimbursement, regulatory approvals, peri-approval and market- Vancouver office: 450 - 688 W. Hastings St., Vancouver B.C. V6B 1P1 Tel: 604-331-8414 Fax: 604-331-8446 Health economics: jennifer. sambrook@oxfordoutcomes. com Epidemiology: shelagh. szabo@oxfordoutcomes.com ing development process. PNM operates to: Companies, Hospitals,Institutions, University Med schools, and small operations requiring radiotherapeutic clinical trial services 2 people located in N. Vancouver Hospital Department that offers clinical trial development of new radiotracer/ radiotherapeutic pharmaceuticals. Offers services primarily to clients in North America and Canada Located at Lions Gate Hospital; specializes in undertaking clinical trials for new biopharmaceuticals which are labeled with radioactive tracers for both radiodiagnosis and radiotherapy. Collaborations with several research groups at the UBC and SFU as well as Vancouver area teaching hospitals. Areas of current interest involve single photon studies for absolute quantitation, multiple simultaneous tracer studies, and dynamic SPECT for groups wishing to introduce new tracers. Collaborations possible through Life Sciences program at TRIUMF for novel radionuclides. Lions Gate Hospital Foundation 231 East 15th Street North Vancouver B.C. V7L 2L7 Head of the Division of Nuclear Medicine: Dr. Philip Cohen Tel : 604-984-5954 cohen@triumf.ca Pacific Nuclear Medicine Inc. (PNM) No URL GCP Operates to GCP Pharmaceutical companies from US, Europe and Canada 11 on staff: 4 study coordinators; 5 investigators located in Victoria, B.C. PerCuro Clinical Research Ltd. No URL 301 All studies conducted on an outpatient basis. PerCuro services the Victoria, Gulf Islands, and South Vancouver Island area of B.C.. Conducts out patient clinical trials for the pharmaceutical industry in the areas of rheumatology, dermatology, gastroenterology and infectious diseases (in particular Hepatitis C). Services include clinical trial management, budget negotiation, and regulatory management. Trials undertaken to date have been Phases II-IV. Principal Investigators are specialists in their field. Research coordinators are all Registered Nurses with most holding their baccalaureate degree. Lab draws and processing are performed on site. All nurse coordinators are certified in IV therapy with a three chair research infusion clinic as part of the site. 200-1105 Pandora Avenue, Victoria, B.C. V8V 3P9 Tel: 250-382-6270 Fax: 250-382-6273 Contact: Leeanna Bulinckx – President. leeanna@percuro. net
Page 1:
1 33 0 34 0 M A G N E T I C V A R 9
Page 4 and 5:
ii BRITISH COLUMBIA
Page 6 and 7:
2 EXECUTIVE SUMMARY BRITISH COLUMBI
Page 8 and 9:
4 INTRODUCTION BRITISH COLUMBIA Wit
Page 10 and 11:
6 Health Authority (URL) Key Facili
Page 12 and 13:
8 FIGURE 2. Clinical Trials Units,
Page 14 and 15:
10 Facility (URL if available) Pedi
Page 16 and 17:
12 Facility (URL if available) Mood
Page 18 and 19:
14 Facility (URL if available) Down
Page 20 and 21:
16 Facility (URL if available) Clin
Page 22 and 23:
18 Facility (URL if available) Gast
Page 24 and 25:
20 TABLE 3. Clinical Trials Support
Page 26 and 27:
22 Much clinical research - particu
Page 28 and 29:
24 FIGURE 3. Source of Funds for Cl
Page 30 and 31:
26 BRITISH COLUMBIA FIGURE 7. Thera
Page 32 and 33:
28 BRITISH COLUMBIA Clinical Invest
Page 34 and 35:
Disease Area Population Information
Page 36 and 37:
32 CV/Cardiology CNS Pulmonary Canc
Page 38 and 39:
34 TABLE 9. Health Economics and He
Page 40 and 41:
36 TABLE 10. Epidemiology and Surve
Page 42 and 43:
38 TABLE 12. Provincial Networks Th
Page 44 and 45:
40 Network B.C. Investigator’s Ro
Page 46 and 47:
42 Network B.C. Investigator’s Ro
Page 48 and 49:
44 TABLE 14. Independent Clinical T
Page 50 and 51:
46 COMPARATIVE POSITIONING OF B.C.
Page 52 and 53:
48 ACKNOWLEDGEMENTS BRITISH COLUMBI
Page 54 and 55:
50 APPENDIX 1-2 TABLE OF CONTENTS B
Page 56 and 57:
52 PROVINCIAL HEALTH SERVICES AUTHO
Page 58 and 59:
54 BRITISH COLUMBIA Edward Miller C
Page 60 and 61:
56 BRITISH COLUMBIA Radiation Thera
Page 62 and 63:
58 The Unit has 15 Principal Invest
Page 64 and 65:
60 BRITISH COLUMBIA Neonatal Resear
Page 66 and 67:
62 The B.C. Children’s Hospital p
Page 68 and 69:
64 BRITISH COLUMBIA The clinical tr
Page 70 and 71:
66 FRASER HEALTH AUTHORITY BRITISH
Page 72 and 73:
68 BRITISH COLUMBIA tional therapis
Page 74 and 75:
70 PROVIDENCE HEALTH CARE SOCIETY 4
Page 76 and 77:
72 BRITISH COLUMBIA Quality control
Page 78 and 79:
74 Clinical trials investigators in
Page 80 and 81:
76 The facility has 13 investigator
Page 82 and 83:
78 Staffing of the Centre is as fol
Page 84 and 85:
80 Investigators: • Ayas, Najib
Page 86 and 87:
82 BRITISH COLUMBIA Quality control
Page 88 and 89:
84 The Research Group consists of t
Page 90 and 91:
86 BRITISH COLUMBIA Multiple Sclero
Page 92 and 93:
88 BRITISH COLUMBIA Gastroenterolog
Page 94 and 95:
Since the Centre is located in St.
Page 96 and 97:
TABLE A1. Providence Health Care So
Page 98 and 99:
94 BRITISH COLUMBIA FIGURE A9. Cent
Page 100 and 101:
96 BRITISH COLUMBIA The Unit suppor
Page 102 and 103:
TABLE A2. CFRI Program-affiliated R
Page 104 and 105:
100 BRITISH COLUMBIA Quality contro
Page 106 and 107:
102 BRITISH COLUMBIA • Knowledge
Page 108 and 109:
104 Its staffing is as follows: Stu
Page 110 and 111:
106 APPENDIX 3. QUALITY CONTROL/ QU
Page 112 and 113:
APPENDIX 5. CLINICAL TRIALS TRAININ
Page 114 and 115:
APPENDIX 5. Clinical Trials Trainin
Page 116 and 117:
112 APPENDIX 6 TABLE OF CONTENTS BR
Page 118 and 119:
6.1 Clinical Trials Researchers Lis
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Pediatrics INSTITUTION EMAIL URL DI
Page 244 and 245:
Pediatrics (cont’d) INSTITUTION E
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
248 APPENDICES 7-13 TABLE OF CONTEN
Page 254 and 255: 250 TABLE A3. Patient and Addiction
Page 256 and 257: 252 TABLE A3. Patient and Addiction
Page 258 and 259: APPENDIX 8. PROVINCIAL AND NATIONAL
Page 260 and 261: APPENDIX 8. Provincial And National
Page 262 and 263: 258 APPENDIX 9. Healthcare Research
Page 264 and 265: APPENDIX 9. Healthcare Research Cen
Page 288 and 289: APPENDIX 10. NATIONAL AND INTERNATI
Page 290 and 291: Networks In Which B.C.’s Clinical
Page 296 and 297: APPENDIX 11. INDEPENDENT CLINICAL T
Page 298 and 299: APPENDIX 11. Independent Clinical T
Page 310 and 311: APPENDIX 12. PRECLINICAL STUDIES SE
Page 312 and 313: APPENDIX 12. Preclinical Studies Se
Page 314 and 315: APPENDIX 12. Preclinical Studies Se
Page 316 and 317: 312 B.C. Centre for Disease Control
Page 318 and 319: 314 University of Victoria Brenda D
Page 320: 316 BRITISH COLUMBIA
show all

Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

Create successful ePaper yourself

Delete template?

Save as template?